Vanguard Group’s Senti Biosciences SNTI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $762K | Buy |
360,911
+206,775
| +134% | +$436K | ﹤0.01% | 3822 |
|
|
2025
Q1 | $518K | Buy |
154,136
+56,669
| +58% | +$190K | ﹤0.01% | 3878 |
|
|
2024
Q4 | $342K | Hold |
97,467
| – | – | ﹤0.01% | 4029 |
|
|
2024
Q3 | $220K | Sell |
97,467
-609,585
| -86% | -$1.38M | ﹤0.01% | 4123 |
|
|
2024
Q2 | $195K | Hold |
707,052
| – | – | ﹤0.01% | 4173 |
|
|
2024
Q1 | $267K | Hold |
707,052
| – | – | ﹤0.01% | 4130 |
|
|
2023
Q4 | $467K | Buy |
707,052
+153,900
| +28% | +$102K | ﹤0.01% | 4053 |
|
|
2023
Q3 | $228K | Hold |
553,152
| – | – | ﹤0.01% | 4232 |
|
|
2023
Q2 | $347K | Buy |
553,152
+37,721
| +7% | +$23.7K | ﹤0.01% | 4210 |
|
|
2023
Q1 | $608K | Hold |
515,431
| – | – | ﹤0.01% | 4065 |
|
|
2022
Q4 | $727K | Buy |
+515,431
| New | +$727K | ﹤0.01% | 4003 |
|